Medtronic plc (MDT) 의 후행 P/E는 24.4, 선행 P/E 15.6. 후행 이익수익률은 4.09%, 선행 이익수익률 6.43%. PEG 0.27 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $55.74.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 69/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 31.5 | 10.99 | 2.15 | 3.87 | 1.92% |
| 2017 | 28.7 | 1.75 | 2.30 | 3.89 | 2.06% |
| 2018 | 35.0 | -1.62 | 2.14 | 3.63 | 2.29% |
| 2019 | 25.8 | 0.51 | 2.39 | 3.91 | 2.25% |
| 2020 | 27.8 | 7.36 | 2.62 | 4.60 | 2.17% |
| 2021 | 48.8 | -1.96 | 3.42 | 5.85 | 1.77% |
| 2022 | 27.8 | 0.70 | 2.67 | 4.42 | 2.41% |
| 2023 | 32.2 | -1.31 | 2.35 | 3.87 | 2.99% |
| 2024 | 28.8 | -13.58 | 2.11 | 3.27 | 3.46% |
| 2025 | 23.2 | 0.75 | 2.25 | 3.23 | 3.32% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2020 | $3.54 | $28.91B | $4.79B | 16.6% |
| 2021 | $2.66 | $30.12B | $3.61B | 12% |
| 2022 | $3.73 | $31.69B | $5.04B | 15.9% |
| 2022 | $3.73 | $31.69B | $5.04B | 15.9% |
| 2023 | $2.82 | $31.23B | $3.76B | 12% |
| 2023 | $2.82 | $31.23B | $3.76B | 12% |
| 2024 | $2.76 | $32.36B | $3.68B | 11.4% |
| 2024 | $2.76 | $32.36B | $3.68B | 11.4% |
| 2025 | $3.61 | $33.54B | $4.66B | 13.9% |
| 2025 | $3.61 | $33.54B | $4.66B | 13.9% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $5.65 | $5.57 – $5.71 | $36.16B | $36.03B – $36.24B | 8 |
| 2027 | $6.08 | $5.99 – $6.24 | $38.64B | $37.39B – $39.3B | 15 |
| 2028 | $6.53 | $5.84 – $7.15 | $40.64B | $40.48B – $40.8B | 9 |
| 2029 | $7.14 | $6.89 – $7.28 | $43.27B | $42.06B – $43.9B | 3 |
| 2030 | $7.77 | $7.49 – $7.92 | $45.56B | $44.28B – $46.23B | 3 |
